Cash Flow

v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Loss from continuing operations $ (586,243) $ (1,431,718) $ (1,393,395) $ (2,541,041)  
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:          
Depreciation and amortization     107,314 279,933  
Deferred income taxes     0 (9,923)  
Noncash lease expense     45,695 45,692  
Stock-based compensation expense     109,670 63,256  
Allowance for credit losses     36,250 832 $ (15,761)
Amortization of commitment funding     (187,500) 0  
Changes in operating assets and liabilities, net of effects of discontinued operations:          
Accounts receivable     265,604 467,460  
Prepaid expenses and other current assets     227,852 219,566  
Accounts payable     61,051 479,816  
Accrued expenses     (43,329) 50,725  
Lease liability     (52,697) (51,471)  
Deferred revenue     55,943 116,188  
Net cash used in operating activities - continuing operations     (767,542) (878,967)  
Net cash used in operating activities - discontinued operations     0 (30,513)  
Net cash used in operating activities     (767,542) (909,480)  
Cash flows from investing activities:          
Payments for technology developed     (150,944) (61,200)  
Purchases of property and equipment     (1,973) (8,375)  
Acquisition of assets of Expo Experts     0 (400,000)  
Additional acquisition of equity interest in RemoteMore USA, Inc.     0 (351,633)  
Net cash used in investing activities     (152,917) (821,208)  
Cash flows from financing activities:          
Proceeds from the sale of common stock     829,989 2,700,000  
Proceeds from noncontrolling interests     82,140 0  
Net cash provided by (used in) financing activities     912,129 2,700,000  
Effect of exchange rate fluctuations on cash and cash equivalents     0 594  
Net decrease in cash and cash equivalents     (8,330) 969,906  
Cash, cash equivalents, beginning of period     627,641 1,236,771 1,236,771
Cash and cash equivalents, end of period $ 619,311 $ 2,206,677 619,311 2,206,677 $ 627,641
Supplemental disclosures of other cash flow information:          
Non-cash stock issuance     0 200,000  
Cash paid for income taxes     $ 0 $ 0  

Source